tenk.fyi

LENZ Therapeutics, Inc.

LENZNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$49.8M

28.9% YoY

EPS

$-2.34

93.4% YoY

Cash

$20.2M

42.6% YoY

FY 2024 · As of 2024-12-31